First of all, you won't be surprised to hear my congratulations for your serious work, Mr. Thériault. Not only is this serious work, this is a serious problem.
Second, you rightly noted that Health Canada gave its approval quickly. One reason in particular was that the department worked with its international partners. I believe we were among the first four countries in the world to approve Paxlovid and the second country in the world to administer it.
Third, provinces and territories already had a fairly large stockpile of Paxlovid and are starting to use it clinically rather effectively. In the last few days, we have had encouraging news regarding the availability of the drug in Quebec's pharmacies.
Fourth, for any other drug, including the Merck company's drug, Health Canada's concerns and obligations are obviously based on the safety and effectiveness of that drug.
If you want to know more, I could turn to the experts at Health Canada.